Georgia Court Finds Dietary Supplement Labeling Claim within FDA’s Jurisdiction

On June 24, the Court of Appeals of Georgia held that Plaintiff Shawn Smith’s deceptive product labeling case raised questions best left to the FDA. By way of background, in 2016, the FDA issued warning letters to seven companies stating that methylsynephrine used in the companies’ dietary supplements does not meet the definition of a... Continue Reading